## 3 Results and Discussion
\begin{table}
\begin{tabular}{c c c c c c c c c c c c c c c} \hline \hline
**No.** & **Protein Name** & **Gene Name** & **Accession** & **N\({}_{\text{2}}\)** & **N\({}_{\text{3}}\)C** & **A** & **AUC** & **O\({}_{\text{2}}\)** & **O\({}_{\text{3}}\)C** & **Pep.** & **Seq.\%** & **pl/Mr** & **Sp.\%** \\
28 &
\begin{tabular}{c} Secreted immunoglobulin gamsual \\ heavy chain constant region, partial \\ \end{tabular} & IGHG & ANN4637 & 2270 & 2201 & 1.03 & 2428 & 1.09 & 287.2 & 0.13 & 14 & 60/79 & 6.07/36.32 & B \\
29 &
\begin{tabular}{c} Immunoglobulin gamma \\ heavy chain \\ \end{tabular} & IGHG & AQTZ700 & 2275 & 1017 & 0.45 & 1618 & 0.71 & 2225 & 0.98 & 26 & 56/89 & 621/50.09 & B \\
30 &
\begin{tabular}{c} heavy chain \\ \end{tabular} & IGHG & AQTZ700 & 2275 & 1017 & 0.45 & 1618 & 0.71 & 2225 & 0.98 & 26 & 56/89 & 621/50.09 & B \\
31 & & & & & & & & & & & & & & \\
32 & & & & & & & & & & & & & & \\
33 & & & & & & & & & & & & & & \\
34 & & & & & & & & & & & & & & \\
35 & & & & & & & & & & & & & & \\
36 & & & & & & & & & & & & & & \\
37 & & & & & & & & & & & & & & \\
38 & & t-RNA specific adenine & ADAT2 & QSt97 & 55.8 & 24.9 & 0.45 & 49.7 & 0.89 & 41.3 & 0.74 & 14 & 61/61 & 633/21.57 & B \\
39 &
\begin{tabular}{c} deaminase 2 \\ \end{tabular} & IGHG & AQTZ700 & 43.2 & 18.5 & 0.43 & 35.8 & 0.83 & 12.3 & 0.28 & 26 & 58/83 & 621/50.09 & B \\
41 &
\begin{tabular}{c} lazy chain dynamic \\ \end{tabular} & IGHG & AQTZ700 & 43.2 & 18.5 & 0.43 & 35.8 & 0.83 & 12.3 & 0.28 & 26 & 58/83 & 621/50.09 & B \\
42 &
\begin{tabular}{c} IgG: heavy chain precursor \\ (B/MT,A1,T2,F4S) \\ \end{tabular} & IGHG & CAA4669 & 25.7 & 18.7 & 0.73 & 21.5 & 0.83 & 5.6 & 0.22 & 22 & 58/91 & 6.10/51.39 & B \\
43 &
\begin{tabular}{c} Alpha-51-cents \\ \end{tabular} & CSNIS1 & P0862 & 283.9 & 58.1 & 0.2 & 45.7 & 0.16 & 34.6 & 0.12 & 6 & 35/59 & 4.48/24.57 & B \\
44 &
\begin{tabular}{c} T-complete protein \\ isodern d \\ \end{tabular} & TCP1 & NP\_002120084 & 668.8 & 643.3 & 0.96 & 2000 & 2.99 & 863.8 & 1.29 & 29 & 72/81 & 5.86/49.55 & H \\ \hline
45 &
\begin{tabular}{c} Unnamed protein product, partial \\ \end{tabular} & CAP0119 & CAP0119 & 1598 & 1723 & 1.14 & 1941 & 1.25 & 710 & 0.46 & 12 & 64/95 & 9.78/13.15 & T \\
46 &
\begin{tabular}{c} PRBEDEC: rx-associated protein \\ \end{tabular} & XP\_02901706 & 4206 & 1057 & 0.25 & 1757 & 0.42 & 1003 & 0.25 & 95 & 45/83 & 8.25/22.35 & MP \\ \hline
47 &
\begin{tabular}{c} hypothetical protein \\ EISS55, (2003), partial \\ \end{tabular} & TCK1646 & TCSK165 & 1185 & 191.5 & 0.16 & 489.4 & 0.41 & 840.7 & 0.71 & 21 & 61/82 & 105/46.66 & MM \\ \hline
48 &
\begin{tabular}{c} Kv channel-interacting protein 1 \\ \end{tabular} & ICK171 & QQNZZ22 & 1325 & 50 & 0.04 & 253.6 & 0.19 & 443.0 & 0.33 & 26 & 81/66 & 5.10/25.97 & H \\ \hline
49 &
\begin{tabular}{c} Gold-cell domain- \\ containing protein 183 \\ \end{tabular} & SCCD183 & XP\_030886 & 3301 & 1156.5 & 0.35 & 1247 & 0.37 & 3818 & 1.15 & 38 & 67/85 & 9.90/32.80 & L \\
50 &
\begin{tabular}{c} containing protein 183 \\ \end{tabular} & 578 & 2019 & 795.5 & 0.37 & 1954 & 0.79 & 2011 & 1 & 37 & 68/85 & 9.90/32.80 & L \\
51 & \
\begin{tabular}{c} isoform X2 \\ \end{tabular} &
52 &
\begin{tabular}{c} Beta-iscloglobulin \\ \end{tabular} & ICB & P02754 & 155.1 & 22.3 & 0.14 & 21.7 & 0.14 & 6.9 & 0.04 & 23 & 96/62 & 493/22.27 & B \\ \hline
54 &
\begin{tabular}{c} Propend{tabular} & P036247 & 31 & 4.2 & 0.14 & 10.9 & 0.35 & 0.2 & 0.01 & 5 & 46/56 & 9.67/20.64 & B \\ \hline \hline \end{tabular}
\end{table} 
Table 6: Conf. In the 1-DE gels, bands of protein fractions were presently smeared and wider compared to the control sample. This may be caused by some cold plasma-induced structural modification resulting in molecular weight changes. These changes are most likely caused by reactive oxygen and nitrogen species and UV radiation, which can potentially modify protein structures [66]. This is supported by the study of [PERSON] et al.